Recommended and observed statin use among U.S. adults - National Health and Nutrition Examination Survey, 2011-2018

Angela M Thompson-Paul1, Cathleen Gillespie2, Hilary K Wall2

  • 1U.S. Public Health Service, Rockville, MD, USA; Division for Heart Disease and Stroke Prevention, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Insights

The 2018 Cholesterol Guideline recommended fewer adults for statin therapy than the 2013 guideline, yet statin use remained suboptimal. Improved patient-clinician discussions are needed to boost treatment rates.

Area of Science:

  • Cardiovascular Medicine
  • Public Health
  • Clinical Guidelines

Background:

  • The American College of Cardiology/American Heart Association (ACC/AHA) published blood cholesterol guidelines in 2013 and a multi-society guideline in 2018.
  • These guidelines provide recommendations for the management of blood cholesterol and cardiovascular disease risk.

Purpose of the Study:

  • To compare population-level estimates of statin recommendations and usage between the 2013 and 2018 cholesterol guidelines.
  • To identify differences in guideline application across various demographic and patient management groups.

Main Methods:

  • Analysis of National Health and Nutrition Examination Survey data (2011-2018) from 8,642 non-pregnant adults.
  • Comparison of statin recommendation prevalence and use based on criteria from the 2013 and 2018 Cholesterol Guidelines.

Main Results:

  • The 2018 Cholesterol Guideline recommended statins for an estimated 46.1 million adults, compared to 77.8 million under the 2013 guideline.
  • Statin use among those recommended for treatment was similar under both guidelines (approximately 47%).
  • Significant differences in recommendations and use were observed across demographic and patient management subgroups.

Conclusions:

  • The 2018 Cholesterol Guideline algorithm resulted in a lower prevalence of statin recommendations but included more individuals for consideration via risk assessment and discussion.
  • Statin utilization remained suboptimal (<50%) for individuals recommended for treatment under both guidelines.
  • Enhancing patient-clinician risk discussions and shared decision-making is crucial for improving statin treatment rates.
Abstract

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
726
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
16
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
27
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
214
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
622
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ...
890